pI: 4.8279 |
Length (AA): 165 |
MW (Da): 18576 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_131531)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G19130 | hypothetical protein |
Dictyostelium discoideum | DDB_G0268166 | hypothetical protein |
Leishmania braziliensis | LbrM.34.1020 | hypothetical protein, unknown function |
Leishmania donovani | LdBPK_351050.1 | zinc finger protein family member, putative |
Leishmania infantum | LinJ.35.1050 | hypothetical protein, unknown function |
Leishmania major | LmjF.35.1030 | zinc finger protein family member, putative |
Leishmania mexicana | LmxM.34.1030 | hypothetical protein, unknown function |
Mycobacterium ulcerans | MUL_4460 | hypothetical protein |
Oryza sativa | 4345750 | Os08g0455800 |
Oryza sativa | 9266408 | Os06g0198600 |
Oryza sativa | 4340398 | Os06g0198500 |
Saccharomyces cerevisiae | YML079W | hypothetical protein |
Trichomonas vaginalis | TVAG_587430 | conserved hypothetical protein |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.